State-wise Status of Multi-Drug Resistant (MDR)/ Rifampicin Resistant (RR) with Additional Resistance Patients Diagnosis and Treatment under National Tuberculosis Elimination Programme (NTEP) in India (2020) | |||||||||
States/UTs | MDR/RR With Additional Resistance Diagnosed | FQ/SLI/InhA/Z Resistance Patients Initiated on Treatment (Other than XDR) | FQ/SLI/InhA/Z Resistance Patients Initiated on Longer Oral Regimen (Other than XDR) | ||||||
FQ Resistance | SLI Resistance | InhA Resistance | Z Resistance | FQ/SLI/InhA/Z Resistance Detected (Other than XDR) | |||||
No. | %age | No. | %age | ||||||
Andaman & Nicobar Islands | |||||||||
Andhra Pradesh | |||||||||
Arunachal Pradesh | |||||||||
Assam | |||||||||
Bihar | |||||||||
Chandigarh | |||||||||
Chhattisgarh | |||||||||
Dadra and Nagar Haveli and Daman and Diu | |||||||||
Delhi | |||||||||
Goa | |||||||||
Gujarat | |||||||||
Haryana | |||||||||
Himachal Pradesh | |||||||||
Jammu & Kashmir | |||||||||
Jharkhand | |||||||||
Karnataka | |||||||||
Kerala | |||||||||
Ladakh | |||||||||
Lakshadweep | |||||||||
Madhya Pradesh | |||||||||
Maharashtra | |||||||||
Manipur | |||||||||
Meghalaya | |||||||||
Mizoram | |||||||||
Nagaland | |||||||||
Odisha | |||||||||
Puducherry | |||||||||
Punjab | |||||||||
Rajasthan | |||||||||
Sikkim | |||||||||
Tamil Nadu | |||||||||
Telangana | |||||||||
Tripura | |||||||||
Uttar Pradesh | |||||||||
Uttarakhand | |||||||||
West Bengal | |||||||||
Eastern India | |||||||||
North-East India | |||||||||
Northern India | |||||||||
Southern India | |||||||||
Western & Central India | |||||||||
Hindi Belt | |||||||||
India |